Pharma Surge

Pharma Surge

🌍·17h agodiscovery

Johnson & Johnson Shares Edge Higher as $3.5B Biotech Moves Expand Oncology Pipeline

Publisher

B
Benzinga

Global

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Benzinga
Region
Global
Scope
discovery
Published
August 1, 2026
Language
EN

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on news.google.com

Leave the platform to read the original full article on the publisher site.

Source: Benzinga

Scope: discovery

Open original article
Johnson & Johnson Shares Edge Higher as $3.5B Biotech Moves Expand Oncology Pipeline | Pharma Surge